Posted on 2/8/2016
Perry offers a full range of monoplace, dual-place and multiplace hyperbaric oxygen therapy (HBOT) systems, FDA-approved for use in the treatment of diabetic wounds, radiation tissue damage (ORN), refractory osteomyelitis, compromised skin grafts & flaps, necrotizing soft tissue infections, thermal burns, decompression sickness, cyanide & carbon monoxide poisoning, ISSHL and much more.
Perry’s focus is on manufacturing innovation, quality, operational safety, patient comfort and service excellence. Perry is a global market leader since 1956.
The Perry Sigma Series includes:
• Full Product Range: Monoplace, Dual Place and Multi-place HBOT Chambers
• 100% Optically-Pure Full Length Acrylic Monoplace Chamber Design
• Extra Durability & Safety Precau...